Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China

Xiaohua Qin; Tianxin Xiang; Xiaoju Zhang; Xuzhu Ma; Weifeng Zhao; Yunsong Yu; Caiyan Zhao; Liang Gao; Lifen Li; Tiantian Wang; Chongjie Pang; Xiaoyu Zhao; Renru Han; Felix Cao; Ming Su; Junchao Lu; Wenjuan Xu; Shan Yin; Danni Lu; Xinyu Yang; Minggui Wang

doi:10.3389/fcimb.2025.1663392

Key Points

Ceftazidime-avibactam shows promising clinical outcomes in real-world settings, enhancing patient care.
Clinical outcomes improved significantly, with distinct microbiological features observed during treatment.
Analysis of treatment patterns across multiple centers provides valuable insights into ceftazidime-avibactam use.
These findings may guide effective antibiotic usage in clinical practice, emphasizing the need for ongoing evaluation.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational analysis highlights treatment patterns and clinical outcomes for ceftazidime-avibactam in China, indicating its real-world relevance.

Abstract

Findings from this study provide important real-world data on treatment patterns, microbiological features, and clinical and microbiological outcomes for CVA in routine clinical practice in China.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Qin et al. (2026) studied this question.

synapsesocial.com/papers/69a75b6dc6e9836116a22b8a https://doi.org/10.3389/fcimb.2025.1663392

View Full Paper

Ask AI

Bookmark

Share

Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Real-world usage, effectiveness, and microbiological features of ceftazidime-avibactam in clinical practice in China

Key Points

Ask about this paper

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading